Monoclonal Gammopathy of Undetermined Significance: Risk for Progression to Cancer, Other Disorders Examined

Monoclonal gammopathy of undetermined significance (MGUS) is associated with an annual 1% risk for progression to multiple myeloma or plasma-cell or lymphoid disorder, and...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news